Maureen Gallant

3.9k total citations · 1 hit paper
34 papers, 3.2k citations indexed

About

Maureen Gallant is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Maureen Gallant has authored 34 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 11 papers in Virology and 5 papers in Molecular Biology. Recurrent topics in Maureen Gallant's work include Immune Cell Function and Interaction (13 papers), HIV Research and Treatment (11 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (10 papers). Maureen Gallant is often cited by papers focused on Immune Cell Function and Interaction (13 papers), HIV Research and Treatment (11 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (10 papers). Maureen Gallant collaborates with scholars based in Canada, United States and Australia. Maureen Gallant's co-authors include Denisa D. Wagner, Kimberly Martinod, Yanming Wang, Mélanie Demers, Siu Ling Wong, Alexander Brill, Allison B. Goldfine, C. Ronald Kahn, Tobias A. Fuchs and A.S. Savchenko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Maureen Gallant

33 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetes primes neutrophils to undergo NETosis, which impairs wound healing

2015 935 citations Siu Ling Wong, Mélanie Demers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maureen Gallant Canada	17	2.2k	975	395	314	303	34	3.2k
Konstantinos Kambas Greece	25	2.2k 1.0×	1.3k 1.3×	611 1.5×	240 0.8×	379 1.3×	48	3.3k
Ioannis Kourtzelis United States	23	1.6k 0.7×	816 0.8×	259 0.7×	176 0.6×	306 1.0×	37	2.6k
Annemieke M. H. Boots Netherlands	34	2.1k 0.9×	822 0.8×	576 1.5×	247 0.8×	251 0.8×	100	3.9k
Ernst Brandt Germany	33	1.6k 0.7×	867 0.9×	237 0.6×	577 1.8×	290 1.0×	55	3.4k
Mona Saffarzadeh Germany	13	1.4k 0.6×	643 0.7×	321 0.8×	127 0.4×	234 0.8×	19	2.2k
Akrivi Chrysanthopoulou Greece	19	1.7k 0.8×	915 0.9×	505 1.3×	146 0.5×	294 1.0×	34	2.6k
Shiva Shahrara United States	37	1.7k 0.7×	1.1k 1.1×	153 0.4×	261 0.8×	222 0.7×	66	3.8k
Maciej Lech Germany	35	1.9k 0.8×	1.2k 1.3×	310 0.8×	88 0.3×	267 0.9×	80	3.7k
Hans Ulrich Scherer Netherlands	34	2.1k 0.9×	1.5k 1.5×	321 0.8×	253 0.8×	296 1.0×	103	4.5k
Jeffrey H. Ruth United States	34	1.5k 0.7×	936 1.0×	172 0.4×	381 1.2×	236 0.8×	60	3.3k

Countries citing papers authored by Maureen Gallant

Since Specialization

Citations

This map shows the geographic impact of Maureen Gallant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Gallant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Gallant more than expected).

Fields of papers citing papers by Maureen Gallant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Gallant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Gallant. The network helps show where Maureen Gallant may publish in the future.

Co-authorship network of co-authors of Maureen Gallant

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Gallant. A scholar is included among the top collaborators of Maureen Gallant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Gallant. Maureen Gallant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fudge, Neva J., et al.. (2018). Proximity of Cytomegalovirus-Specific CD8+ T Cells to Replicative Senescence in Human Immunodeficiency Virus-Infected Individuals. Frontiers in Immunology. 9. 201–201. 10 indexed citations

Hayashi, Hideki, Deya Cherpokova, Kimberly Martinod, et al.. (2017). Sirt3 deficiency does not affect venous thrombosis or NETosis despite mild elevation of intracellular ROS in platelets and neutrophils in mice. PLoS ONE. 12(12). e0188341–e0188341. 10 indexed citations

Martinod, Kimberly, Thilo Witsch, Luise Erpenbeck, et al.. (2016). Peptidylarginine deiminase 4 promotes age-related organ fibrosis. The Journal of Experimental Medicine. 214(2). 439–458. 168 indexed citations

Demers, Mélanie, Siu Ling Wong, Kimberly Martinod, et al.. (2016). Priming of neutrophils toward NETosis promotes tumor growth. OncoImmunology. 5(5). e1134073–e1134073. 196 indexed citations

Erpenbeck, Luise, Chanchal Sur Chowdhury, Zsuzsanna K. Zsengellér, et al.. (2016). PAD4 Deficiency Decreases Inflammation and Susceptibility to Pregnancy Loss in a Mouse Model. Biology of Reproduction. 95(6). 132–132. 36 indexed citations

Gallant, Maureen, et al.. (2015). Heteroclitic Peptides Increase Proliferation and Reduce Evidence of Human Immunodeficiency Virus-Specific CD8 ⁺ T Cell Dysfunction. Viral Immunology. 28(8). 455–463. 5 indexed citations

Erpenbeck, Luise, Mélanie Demers, Zsuzsanna K. Zsengellér, et al.. (2015). ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor–Induced Thrombotic Microangiopathy. Journal of the American Society of Nephrology. 27(1). 120–131. 13 indexed citations

Thomas, Grace M., Alexander Brill, Soraya Mezouar, et al.. (2015). Tissue factor expressed by circulating cancer cell‐derived microparticles drastically increases the incidence of deep vein thrombosis in mice. Journal of Thrombosis and Haemostasis. 13(7). 1310–1319. 122 indexed citations

Martinod, Kimberly, Thilo Witsch, Kristen R. Farley, et al.. (2015). Neutrophil elastase‐deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis. Journal of Thrombosis and Haemostasis. 14(3). 551–558. 147 indexed citations

10.

Gallant, Maureen, et al.. (2014). Positioning of APOBEC3G/F Mutational Hotspots in the Human Immunodeficiency Virus Genome Favors Reduced Recognition by CD8+ T Cells. PLoS ONE. 9(4). e93428–e93428. 41 indexed citations

11.

Gallant, Maureen, et al.. (2014). Greater frequency of CD5-negative CD8+ T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation. AIDS Research and Therapy. 11(1). 30–30. 4 indexed citations

12.

Savchenko, A.S., Julian Ilcheff Borissoff, Kimberly Martinod, et al.. (2013). VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. Blood. 123(1). 141–148. 230 indexed citations

13.

Martinod, Kimberly, Mélanie Demers, Tobias A. Fuchs, et al.. (2013). Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proceedings of the National Academy of Sciences. 110(21). 8674–8679. 427 indexed citations

14.

Parsons, Matthew S., et al.. (2010). Distinct Phenotype of Unrestricted Cytotoxic T lymphocytes from Human Immunodeficiency Virus-infected Individuals. Journal of Clinical Immunology. 30(2). 272–279. 1 indexed citations

15.

Gallant, Maureen, et al.. (2010). Human immunodeficiency virus type I-specific CD8+T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy. BMC Infectious Diseases. 10(1). 129–129. 12 indexed citations

16.

Barrett, Lisa Feldman, et al.. (2008). Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals. BMC Immunology. 9(1). 28–28. 20 indexed citations

17.

Mason, Rosemarie D., et al.. (2004). Antiretroviral Drug Resistance Mutations Sustain or Enhance CTL Recognition of Common HIV-1 Pol Epitopes. The Journal of Immunology. 172(11). 7212–7219. 37 indexed citations

18.

Kottilil, Shyamasundaran, et al.. (2000). Human Immunodeficiency Virus Type 1 Replication,Immune Activation, and Circulating CytotoxicT Cells Against Uninfected CD4+ T Cells. Journal of Clinical Immunology. 20(3). 175–186. 7 indexed citations

19.

Bérubé, Gervais, et al.. (1995). Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro. Bioorganic & Medicinal Chemistry. 3(10). 1305–1312. 30 indexed citations

20.

Richardson, Vernon J., et al.. (1989). Doxorubicin-Anti-carcinoembryonic antigen immunoconjugate activity in vitro. European Journal of Cancer and Clinical Oncology. 25(4). 633–640. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact